These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vitro susceptibilities of 180 clinical isolates of Haemophilus influenzae to ampicillin, amoxycillin/clavulanate, cefaclor, cefuroxime, cefotaxime, clarithromycin, and azithromycin. Delmée M, Carpentier M, Glupczynski Y, Gordts B, Magerman K, Simon A, Surmont I, Van de Vyvere M, Van Landuyt H, Van Nimmen L, Van Noyen R. Acta Clin Belg; 1996; 51(4):237-43. PubMed ID: 8858889 [Abstract] [Full Text] [Related]
6. Are beta-lactam breakpoints adequate to define non-susceptibility for all Haemophilus influenzae resistance phenotypes from a pharmacodynamic point of view? Alou L, Giménez MJ, Sevillano D, Aguilar L, González N, Echeverría O, Torrico M, Coronel P, Prieto J. J Antimicrob Chemother; 2007 Apr; 59(4):652-7. PubMed ID: 17341471 [Abstract] [Full Text] [Related]
10. Novel mechanisms of resistance to β-lactam antibiotics in Haemophilus parainfluenzae: β-lactamase-negative ampicillin resistance and inhibitor-resistant TEM β-lactamases. García-Cobos S, Arroyo M, Campos J, Pérez-Vázquez M, Aracil B, Cercenado E, Orden B, Lara N, Oteo J. J Antimicrob Chemother; 2013 May; 68(5):1054-9. PubMed ID: 23335113 [Abstract] [Full Text] [Related]
11. Differentiation of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae from other H. influenzae strains by a disc method. Ubukata K, Chiba N, Hasegawa K, Shibasaki Y, Sunakawa K, Nonoyama M, Iwata S, Konno M. J Infect Chemother; 2002 Mar; 8(1):50-8. PubMed ID: 11957120 [Abstract] [Full Text] [Related]